Amendment to Employment Agreement between ImmuCell Corporation and Michael F. Brigham
ImmuCell Corporation and Michael F. Brigham have agreed to amend and replace their previous employment agreement. Under this new agreement, Mr. Brigham will serve as President and CEO of ImmuCell Corporation on an at-will basis, meaning his employment can be terminated by the Board at any time, with or without cause. This amendment, along with related confidentiality and stock option agreements, forms the complete understanding of Mr. Brigham's employment terms with the company.
IMMUCELL CORPORATION
EXHIBIT 10.6
AMENDMENT TO EMPLOYMENT AGREEMENT
IMMUCELL CORPORATION, a Delaware corporation (the Company), and MICHAEL F. BRIGHAM, an individual residing in Kennebunk, Maine (Brigham), hereby agree as follows as of this 26th day of March 2010.
1. This agreement supersedes and replaces in its entirety the Employment Agreement, dated as of April 29, 1999, between the Company and Brigham. This agreement, together with the Confidential Information, Inventions and Noncompete Agreement, dated of even date herewith, between the Company and Brigham and any stock option agreements previously entered into between the Company and Brigham, constitute the parties entire understanding with respect to Brighams employment by the Company.
2. Brigham shall serve as President and Chief Executive Officer of the Company in an at will capacity on such terms as the Board of Directors of the Company may from time to time determine, subject to termination by the Board of Directors of the Company at any time, with or without cause.
IN WITNESS WHEREOF, the parties hereto have executed this Agreement, intending the same to take effect as a sealed instrument, as of the date first above written.
IMMUCELL CORPORATION | ||
By: | /s/ Linda Rhodes | |
Dr. Linda Rhodes | ||
Chair of Compensation and | ||
Stock Option Committee | ||
/s/ | Michael F. Brigham | |
Michael F. Brigham |